Stock Screener ETF Screener

Penny Stock Screener Technical Analysis Screener

Dividend Center Best Dividend Stocks

Best High Yield Dividend Stocks Dividend Aristocrats Dividend Stock Comparison

Dividend Calculator Dividend Returns Comparison Dividend Calendar

My Experts Top Analysts Top Financial Bloggers Top-Performing Corporate Insiders Top Hedge Fund Managers Top Research Firms Top Individual Investors

Education

Personal Finance How To Use TipRanks TipRanks Labs Webinar Center Glossary FAQs

About Us

About TipRanks Contact Us Careers Reviews Mobile APP

Working with TipRanks

Enterprise Solutions Advertise with Us Top Online Brokers Become an Affiliate TipRanks News Wire Arrived EquityMultiple

Follow Us

TOOLS

Top Insiders Stocks

Notification Center

Top Smart Score Stocks

Plans & Pricing

Research Tools

Trending Stocks

Most Visited Websites

Daily Feeds

Daily Analyst Ratings

Daily Insider Trading Tracker

Calendars

Earnings Calendar

Dividend Calendar

Economic Calendar

Market Holidays

Economic Indicators

Economic Indicators Center

Unemployment Rate

Federal Funds Rate

Class Actions

Calculators

Dividend Calculator

Dividend Yield Calculator

Options Profit Calculator

Dollar Cost Averaging

Penny Stock Screener

Technical Analysis Screener

Dividend Center

Best Dividend Stocks

Best High Yield Dividend Stocks

Dividend Aristocrats

Dividend Stock Comparison

Dividend Calculator

Dividend Returns Comparison

Dividend Calendar

Top Financial Bloggers

Top-Performing Corporate Insiders

Top Hedge Fund Managers

Top Research Firms

Top Individual Investors

Personal Finance Center

Investing & Retirement

Spending & Savings

Calculators

Compound Interest Calculator

Mortgage Calculator

Auto Loan Calculator

Student Loan Calculator

401k Retirement Calculator

Enterprise Solutions

Education

How To Use TipRanks

About Us

Working with TipRanks

Enterprise Solutions

Top Online Brokers

Become an Affiliate

TipRanks News Wire

Follow Us

Pharmaust Limited (DE:ECQ0)

:ECQ0

Germany Market

ECQ0

Pharmaust Limited

Analyst Forecasts

Technical Analysis

RESEARCH TOOLS

Top Analyst Stocks

Top Smart Score Stocks

reports

Holding DE:ECQ0?

Track your performance easily

Pharmaust Limited (ECQ0) Stock News & Sentiment

2 Followers

Neurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application

Company Announcements

Neurizon Therapeutics Faces FDA Hold on NUZ-001 IND Application

3d ago

Neurizon Therapeutics Enhances Shareholder Services with Registry Switch

Company Announcements

Neurizon Therapeutics Enhances Shareholder Services with Registry Switch

4d ago

Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push

Company Announcements

Neurizon Therapeutics Expands Shareholding Amid ALS Treatment Push

23d ago

Neurizon Therapeutics Lists New Shares on ASX

Company Announcements

Neurizon Therapeutics Lists New Shares on ASX

23d ago

Neurizon Therapeutics Moves Forward with ALS Trial

Company Announcements

Neurizon Therapeutics Moves Forward with ALS Trial

1M ago

Neurizon Secures EU Orphan Status for ALS Drug

Company Announcements

Neurizon Secures EU Orphan Status for ALS Drug

1M ago

Neurizon Therapeutics Sets Positive 2025 Outlook

Company Announcements

Neurizon Therapeutics Sets Positive 2025 Outlook

1M ago

More DE:ECQ0 News >

ECQ0 News on the Web

2025-01-06

Health Kick Podcast: Neurizon gears up for big year in tackling ALS

StockHead

Neutral

2024-12-23

Petra Capital Reaffirms Their Buy Rating on Pharmaust Limited (ECQ0)

TipRanks News

Bullish

2024-12-22

Stocking stuffers: Morgans#8217; top ASX health picks for 2025

StockHead

Neutral

2024-12-20

Scott Power: Which stock fell off its perch on poor trial results this week?

StockHead

Neutral

2024-12-19

In big news week Neurizon secures key orphan status for motor neurone drug in Europe

StockHead

Neutral

2024-12-18

Neurizon files key IND application with US FDA for motor neurone disease drug

StockHead

Neutral

2024-12-18

Health Check: It#8217;s a wipe out! Percheron shares tumble up to 91pc on rare genetic disease trial failure

StockHead

Neutral

2024-12-16

Neurizon Secures EU Orphan Status for ALS Drug

TipRanks News

Neutral

News Score - Last 7 Days

Neutral

DE:ECQ0

Sector Average

Media Buzz

This Week0 articles

Weekly Average0 articles

News Sentiment

This Week59%

Sector Average69%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:ECQ0’s Media Buzz Sentiment?

Currently, no data Available

What is DE:ECQ0’s weekly average amount of articles?

Currently, no data Available

What is DE:ECQ0’s News Sentiment?

59% of articles about DE:ECQ0 were positive this week, compared to its sector average of 69%.

Healthcare Stocks that are Trending in the News

ATECAlphatec Holdings

APLSApellis Pharmaceuticals

BWAYBrainsway

ILMNIllumina

EXASExact Sciences

Showing the stocks with the most bullish news sentiment over the past week

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing